COVID-19 (2019-nCoV) test
We proudly offer testing for COVID-19 (2019-nCoV) using the SARS-CoV-2 Real-time RT-PCR Diagnostic Panel.
Testing is offered under Emergency Use Authorization (EUA).
Our average turnaround time for COVID-19 sample result reporting.
(Data as of 10/19/2020)
Introducing COVID-19 testing with Acutis Reveal™
Acutis Diagnostics has released a multiplex laboratory test for the detection of SARS-CoV-2, the causative agent of COVID-19.
Offered under an Emergency Use Authorization (EUA), our test validation shows >99% sensitivity and 100% specificity within our test environment. The assay is using a standard nasopharyngeal specimen from which Acutis extracts viral RNA and then tests for the presence of key genes that can be used to identify its presence.
The Acutis SARS-CoV-2 test is a multiplex assay that targets three key genes — ORF1ab, N, and E — that scientists believe are key to accurately identifying the presence of the virus in patient samples.
Section 3202(b) of the Coronavirus Aid, Relief, and Economic Security (CARES) Act requires all providers offering laboratory tests for COVID-19 to make public the cash price of a COVID-19 diagnostic test.
Acutis’ SARS-CoV-2 (COVID-19) testing cash price is $200.00.
Acutis’ SARS-CoV-2 (COVID-19) Antibody testing cash price is $75.00 per unit.
Note: This assay is to be ordered under the guidelines issued by the CDC and various departments of health to identify the presence of the virus in symptomatic patients who have tested negative for other respiratory viruses.
During the Public Health Emergency, most insurances will cover COVID-19 testing at no cost share. Note that some insurances may deny coverage due to medical necessity for asymptomatic persons. Surveillance testing for travel, employment, or school purposes is not covered by insurance. Please reach out to your Acutis representative or contact us with any questions.